Drugs / AT04A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02508896 | Jul 2015 → May 2016 | hyperlipidemia | Affiris AG | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AT04A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02508896 ↗ |
| Modality | Peptide | “AT04A and AT06A are two AFFITOPE® peptide vaccine candidates” PMID 33969434 ↗ May 2021 |